Identification of the semaphorin receptor PLXNA2 as a candidate for susceptibility to schizophrenia

Molecular Psychiatry

Volumn 11, Issue 5, 2006, Pages 471-478

  Mah, S ^a   Nelson, M R ^a   DeLisi, L E ^b   Reneland, R H ^a   Markward, N ^a   James, M R ^c   Nyholt, D R ^c   Hayward, N ^c   Handoko, H ^c   Mowry, B ^c   Kammerer, S ^a   Braun, A ^a  

^a SEQUENOM INC   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Chromosome 1q32; Genome wide association; Plexin; Semaphorin; Single nucleotide polymorphism

Indexed keywords

MEMBRANE RECEPTOR; PLEXIN; PLEXIN A2; SEMAPHORIN; SEMAPHORIN 3A; SEMAPHORIN RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASIAN AMERICAN; CASE CONTROL STUDY; CEREBELLUM; CHROMOSOME 1Q; CONTROLLED STUDY; EUROPE; EUROPEAN AMERICAN; EVIDENCE BASED MEDICINE; FAMILY STUDY; FEMALE; GENE; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENOTYPE; HEREDITY; HISPANIC; HUMAN; LIGAND BINDING; MAJOR CLINICAL STUDY; MALE; NERVE CELL PLASTICITY; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; PLXNA2 GENE; PRIORITY JOURNAL; PROTEIN FAMILY; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NERVE TISSUE PROTEINS; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CELL SURFACE; REFERENCE VALUES; SCHIZOPHRENIA; SEMAPHORIN-3A;

EID: 33646229252     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/sj.mp.4001785     Document Type: Article

References (53)

1. Jablensky A, Sartorius N. Is schizophrenia universal? Acta Psychiatr Scand Suppl 1988; 344: 65-70.
2. Kendler KS. The genetics of schizophrenia: an overview. In: Tsuang MTaS JC (ed) Handbook of Schizophrenia. Amsterdam: Elsevier, 1988, pp 437-462.
3. Chowdari KV, Mirnics K, Semwal P, Wood J, Lawrence E, Bhatia T et al. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet 2002; 11: 1373-1380.
4. Blackwood DH, Fordyce A, Walker MT, St Clair DM, Porteous DJ, Muir WJ. Schizophrenia and affective disorders - cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am J Hum Genet 2001; 69: 428-433.
5. Straub RE, Jiang Y, MacLean CJ, Ma Y, Webb BT, Myakishev MV et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 2002; 71: 337-348.
6. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002; 71: 877-892.
7. Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim H et al. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA 2002; 99: 13675-13680.
8. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 2001; 98: 6917-6922.
9. Liu H, Heath SC, Sobin C, Roos JL, Galke BL, Blundell ML et al. Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proc Natl Acad Sci USA 2002; 99: 3717-3722.
10. Bray NJ, Owen MJ. Searching for schizophrenia genes. Trends Mol Med 2001; 7: 169-174.
11. O'Donovan MC, Williams NM, Owen MJ. Recent advances in the genetics of schizophrenia. Hum Mol Genet 2003; 12: R125-R133.
12. Ozaki K, Ohnishi Y, Iida A, Sekine A, Yamada R, Tsunoda T et al. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 2002; 32: 650-654.
13. Reneland RH, Mah S, Kammerer S, Hoyal CR, Marnellos G, Wilson SG et al. Association between a variation in the phosphodiesterase 4D gene and bone mineral density. BMC Med Genet 2005; 6: 9.
14. Kammerer S, Roth RB, Reneland R, Marnellos G, Hoyal CR, Markward NJ et al. Large-scale association study identifies ICAM gene region as breast and prostate cancer susceptibility locus. Cancer Res 2004; 64: 8906-8910.
15. Kammerer S, Roth RB, Hoyal CR, Reneland R, Marnellos G, Kiechle M et al. Association of the NuMA region on chromosome 11q13 with breast cancer susceptibility. Proc Natl Acad Sci USA 2005; 102: 2004-2009.
16. Hovatta I, Varilo T, Suvisaari J, Terwilliger JD, Ollikainen V, Arajarvi R et al. A genomewide screen for schizophrenia genes in an isolated Finnish subpopulation, suggesting multiple susceptibility loci. Am J Hum Genet 1999; 65: 1114-1124.
17. Brzustowicz LM, Hodgkinson KA, Chow EW, Honer WG, Bassett AS. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science 2000; 288: 678-682.
18. Ekelund J, Hovatta I, Parker A, Paunio T, Varilo T, Martin R et al. Chromosome 1 loci in Finnish schizophrenia families. Hum Mol Genet 2001; 10: 1611-1617.
19. Gurling HM, Kalsi G, Brynjolfson J, Sigmundsson T, Sherrington R, Mankoo BS et al. Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. Am J Hum Genet 2001; 68: 661-673.
20. Hwu HG, Liu CM, Fann CS, Ou-Yang WC, Lee SF. Linkage of schizophrenia with chromosome 1q loci in Taiwanese families. Mol Psychiatry 2003; 8: 445-452.
21. DeLisi LE, Shaw SH, Crow TJ, Shields G, Smith AB, Larach VW et al. A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. Am J Psychiatry 2002; 159: 803-812.
22. Levinson DF, Holmans PA, Laurent C, Riley B, Pulver AE, Gejman PV et al. No major schizophrenia locus detected on chromosome 1q in a large multicenter sample. Science 2002; 296: 739-741.
23. Maziade M, Fournier A, Phaneuf D, Cliche D, Fournier JP, Roy MA et al. Chromosome 1q12-q22 linkage results in eastern Quebec families affected by schizophrenia. Am J Med Genet 2002; 114: 51-55.
24. Suarez BK, Duan J, Sanders A, Hinrichs CH, Jin CH, Buccola NG et al. Genomewide linkage scan of 409 European ancestry and African American families with schizophrenia: suggestive evidence for linkage in 8p23.3-p12 and 11p11.2-q22.3 in the combined sample. Am J Hum Genet, (in press).
25. Nurnberger Jr JI, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J et al. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 1994; 51: 849-859 (discussion 863-864).
26. Gershon ES, DeLisi LE, Hamovit J, Nurnberger Jr JI, Maxwell ME, Schreiber J et al. A controlled family study of chronic psychoses. Schizophrenia and schizoaffective disorder. Arch Gen Psychiatry 1988; 45: 328-336.
27. Maxwell ME. Family Interview for Genetic Studies (FIGS): A Manual for FIGS. Clinical Neurogenetics Branch, Intramural Research Program, National Institute of Mental Health: Bethesda, MD, 1992.
28. Leckman JF, Sholomskas D, Thompson WD, Belanger A, Weissman MM. Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch Gen Psychiatry 1982; 39: 879-883.
29. Mowry BJ, Ewen KR, Nancarrow DJ, Lennon DP, Nertney DA, Jones HL et al. Second stage of a genome scan of schizophrenia: study of five positive regions in an expanded sample. Am J Med Genet 2000; 96: 864-869.
30. Mowry BJ, Holmans PA, Pulver AE, Gejman PV, Riley B, Williams NM et al. Multicenter linkage study of schizophrenia loci on chromosome 22q. Mol Psychiatry 2004; 9: 784-795.
31. Nelson MR, Marnellos G, Kammerer S, Hoyal CR, Shi MM, Cantor CR et al. Large-scale validation of single nucleotide polymorphisms in gene regions. Genome Res 2004; 14: 1664-1668.
32. Buetow KH, Edmonson M, MacDonald R, Clifford R, Yip P, Kelley J et al. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc Natl Acad Sci USA 2001; 98: 581-584.
33. Bansal A, van den Boom D, Kammerer S, Honisch C, Adam G, Cantor CR et al. Association testing by DNA pooling: an effective initial screen. Proc Natl Acad Sci USA 2002; 99: 16871-16874.
34. Mohlke KL, Erdos MR, Scott LJ, Fingerlin TE, Jackson AU, Silander K et al. High-throughput screening for evidence of association by using mass spectrometry genotyping on DNA pools. Proc Natl Acad Sci USA 2002; 99: 16928-16933.
35. Barratt BJ, Payne F, Rance HE, Nutland S, Todd JA, Clayton DG. Identification of the sources of error in allele frequency estimations from pooled DNA indicates an optimal experimental design. Ann Hum Genet 2002; 66(Parts 5-6): 393-405.
36. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003; 25: 115-121.
37. Winberg ML, Noordermeer JN, Tamagnone L, Comoglio PM, Spriggs MK, Tessier-Lavigne M et al. Plexin A is a neuronal semaphorin receptor that controls axon guidance. Cell 1998; 95: 903-916.
38. Cheng HJ, Bagri A, Yaron A, Stein E, Pleasure SJ, Tessier-Lavigne M. Plexin-A3 mediates semaphorin signaling and regulates the development of hippocampal axonal projections. Neuron 2001; 32: 249-263.
39. Kikuchi K, Kishino A, Konishi O, Kumagai K, Hosotani N, Saji I et al. In vitro and in vivo characterization of a novel semaphorin 3A inhibitor, SM-216289 or xanthofulvin. J Biol Chem 2003; 278: 42985-42991.
40. Tamagnone L, Artigiani S, Chen H, He Z, Ming GI, Song H et al. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 1999; 99: 71-80.
41. Rohm B, Ottemeyer A, Lohrum M, Puschel AW. Plexin/neuropilin complexes mediate repulsion by the axonal guidance signal semaphorin 3A. Mech Dev 2000; 93: 95-104.
42. Sawa A, Snyder SH. Schizophrenia: diverse approaches to a complex disease. Science 2002; 296: 692-695.
43. Harrison PJ. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 1999; 122(Part 4): 593-624.
44. Innocenti GM, Ansermet F, Parnas J. Schizophrenia, neurodevelopment and corpus callosum. Mol Psychiatry 2003; 8: 261-274.
45. Raine A, Harrison GN, Reynolds GP, Sheard C, Cooper JE, Medley I. Structural and functional characteristics of the corpus callosum in schizophrenics, psychiatric controls, and normal controls. A magnetic resonance imaging and neuropsychological evaluation. Arch Gen Psychiatry 1990; 47: 1060-1064.
46. Frumin M, Golland P, Kikinis R, Hirayasu Y, Salisbury DF, Hennen J et al. Shape differences in the corpus callosum in first-episode schizophrenia and first-episode psychotic affective disorder. Am J Psychiatry 2002; 159: 866-868.
47. Murakami Y, Suto F, Shimizu M, Shinoda T, Kameyama T, Fujisawa H. Differential expression of plexin-A subfamily members in the mouse nervous system. Dev Dyn 2001; 220: 246-258.
48. Eastwood SL, Law AJ, Everall IP, Harrison PJ. The axonal chemorepellant semaphorin 3A is increased in the cerebellum in schizophrenia and may contribute to its synaptic pathology. Mol Psychiatry 2003; 8: 148-155.
49. Macgregor S, Visscher PM, Knott S, Porteous D, Muir W, Millar K et al. Is schizophrenia linked to chromosome 1q? Science 2002; 298: 2277, (author reply 2277).
50. Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, Semple CA et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 2000; 9: 1415-1423.
51. Detera-Wadleigh SD, Badner JA, Berrettini WH, Yoshikawa T, Goldin LR, Turner G et al. A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. Proc Natl Acad Sci USA 1999; 96: 5604-5609.
52. Moller HJ. Bipolar disorder and schizophrenia: distinct illnesses or a continuum? J Clin Psychiatry 2003; 64(Suppl 6): 23-27 (discussion 28).
53. Berrettini W. Evidence for shared susceptibility in bipolar disorder and schizophrenia. Am J Med Genet 2003; 123C: 59-64.